PL368049A1 - Próby diagnostyczne dla parwowirusa B19 - Google Patents

Próby diagnostyczne dla parwowirusa B19

Info

Publication number
PL368049A1
PL368049A1 PL02368049A PL36804902A PL368049A1 PL 368049 A1 PL368049 A1 PL 368049A1 PL 02368049 A PL02368049 A PL 02368049A PL 36804902 A PL36804902 A PL 36804902A PL 368049 A1 PL368049 A1 PL 368049A1
Authority
PL
Poland
Prior art keywords
parvovirus
diagnostic assays
primers
probes
genome
Prior art date
Application number
PL02368049A
Other languages
English (en)
Other versions
PL210849B1 (pl
Inventor
Sergio Pichuantes
Venkatakrishna Shyamala
Original Assignee
Chiron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corporation filed Critical Chiron Corporation
Publication of PL368049A1 publication Critical patent/PL368049A1/pl
Publication of PL210849B1 publication Critical patent/PL210849B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Wynalazek ujawnia startery i sondy ludzkiego parwowirusa B19, pochodzące z konserwowanych regionów genomu parwowirusa B19. Omawia się także, oparte o kwas nukleinowy, próby z zastosowaniem tych starterów i sond.
PL368049A 2001-06-28 2002-06-28 Sposób wykrywania ludzkiego parwowirusa B19 w próbce biologicznej PL210849B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30207701P 2001-06-28 2001-06-28
US36595602P 2002-03-19 2002-03-19
US36922402P 2002-03-29 2002-03-29

Publications (2)

Publication Number Publication Date
PL368049A1 true PL368049A1 (pl) 2005-03-21
PL210849B1 PL210849B1 (pl) 2012-03-30

Family

ID=28794978

Family Applications (1)

Application Number Title Priority Date Filing Date
PL368049A PL210849B1 (pl) 2001-06-28 2002-06-28 Sposób wykrywania ludzkiego parwowirusa B19 w próbce biologicznej

Country Status (20)

Country Link
US (2) US6936442B2 (pl)
EP (1) EP1537235B1 (pl)
JP (5) JP2005511004A (pl)
KR (2) KR100944674B1 (pl)
CN (1) CN1324147C (pl)
AU (2) AU2002318450B2 (pl)
BG (1) BG66283B1 (pl)
BR (1) BRPI0211191B8 (pl)
CA (2) CA2451756A1 (pl)
CZ (1) CZ308201B6 (pl)
ES (1) ES2537549T3 (pl)
HK (1) HK1080516B (pl)
HU (1) HU230244B1 (pl)
MX (1) MXPA03011802A (pl)
NO (1) NO337901B1 (pl)
NZ (1) NZ530602A (pl)
PL (1) PL210849B1 (pl)
RU (1) RU2301263C2 (pl)
SK (1) SK15752003A3 (pl)
WO (1) WO2003002753A2 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094541B2 (en) 2001-08-31 2006-08-22 Gen-Probe Incorporated Assay for detection of human parvovirus B19 nucleic acid
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
WO2006031608A2 (en) * 2004-09-10 2006-03-23 Focus Diagnostics, Inc. Methods and compositions for detecting erythrovirus genotypes
CA2582661C (en) * 2004-11-09 2015-08-11 Gen-Probe Incorporated Compositions and methods for detecting group a streptococci
US7572584B2 (en) * 2005-06-02 2009-08-11 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
US8058000B2 (en) * 2005-06-02 2011-11-15 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
US20100196875A1 (en) 2007-01-16 2010-08-05 Talecris Biotherapeutics, Inc. Human erythrovirus
NZ614571A (en) * 2007-06-14 2014-12-24 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20110045456A1 (en) * 2007-06-14 2011-02-24 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
EP2300819A4 (en) * 2008-07-23 2011-11-23 Nat Univ Gyeongsang Iacf METHOD AND SYSTEM FOR VIRUS DIAGNOSIS
EP3118208A1 (en) 2009-02-26 2017-01-18 Gen-Probe Incorporated Assay for detection of human parvovirus nuleic acid
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
JP2013529894A (ja) * 2010-04-07 2013-07-25 ノバルティス アーゲー パルボウイルスｂ１９のウイルス様粒子を生成するための方法
WO2013012708A1 (en) 2011-07-15 2013-01-24 Gen-Probe Incorporated Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays
CN103451320B (zh) * 2013-08-09 2015-05-06 中国人民解放军军事医学科学院野战输血研究所 人细小病毒B19三种基因型的实时荧光定量PCR检测方法及其通用检测引物、TaqMan探针与试剂盒
US9410172B2 (en) * 2013-09-16 2016-08-09 General Electric Company Isothermal amplification using oligocation-conjugated primer sequences
CN110845581A (zh) 2014-03-10 2020-02-28 路易斯维尔大学研究基金会有限公司 用于治疗(包括预防)细小病毒感染及相关疾病的组合物和方法
CN103820581B (zh) * 2014-03-17 2016-01-13 成都蓉生药业有限责任公司 一种检测人细小病毒b19的试剂盒和方法
JP6414409B2 (ja) * 2014-07-29 2018-10-31 株式会社微生物化学研究所 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン
US20180155798A1 (en) * 2014-11-05 2018-06-07 Indian Council Of Medical Research In-Vitro Detection of Human Parvovirus 4
TWI735433B (zh) * 2015-03-27 2021-08-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法
CN105158471A (zh) * 2015-08-24 2015-12-16 北京中检安泰诊断科技有限公司 人细小病毒B19型IgM抗体检测试剂盒及其制备方法
CN114410836B (zh) * 2021-12-17 2024-03-01 上海交通大学医学院附属仁济医院 一种集样本处理、核酸提取及多重恒温扩增一体化的检测人细小病毒b19的试剂盒和方法
CN116769971A (zh) * 2023-07-24 2023-09-19 苏州天隆生物科技有限公司 检测人细小病毒b19的双靶标引物探针组、试剂盒及检测方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516630A (en) 1983-09-30 1996-05-14 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting hepatitis A virus
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US6204044B1 (en) 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6379885B1 (en) 1989-09-14 2002-04-30 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
DE4003826C2 (de) 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
WO1994010294A1 (en) 1992-10-23 1994-05-11 New York University Human monoclonal antibodies to human parvovirus and methods of making and using thereof
US5449608A (en) 1993-03-22 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Parvovirus B19 receptor and parvovirus B19 detection
JPH06293798A (ja) 1993-04-06 1994-10-21 Shin Etsu Chem Co Ltd ヒトパルボウイルスｂ１９のエピトープ関連ペプチド
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
AU3698595A (en) 1994-09-22 1996-04-09 Hans Wolf Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
US6004044A (en) * 1995-05-03 1999-12-21 Itt Cannon, Inc. Optoelectric connector
JPH0910000A (ja) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya ヒトパルボウイルスの検出方法及びそのための試薬
IL124348A (en) * 1995-11-13 2001-10-31 Shionogi & Co Identification of gene mutations in ENDOTHELIAL NITROGEN MONOXIDE SYNTHASE (eNOS) for the diagnosis and detection of coronary artery disease
AU6267596A (en) 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
US6094338A (en) * 1997-07-09 2000-07-25 Mitsubishi Chemical Corporation Electric double-layer capacitor
WO1999018227A1 (en) 1997-10-08 1999-04-15 Advanced Research And Technology Institute Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
DE19752898A1 (de) 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
CA2318880C (en) 1998-02-04 2010-07-27 Applied Biosystems, Llc Determination of a genotype of an amplification product at multiple allelic sites
RU2146372C1 (ru) * 1998-04-16 2000-03-10 Гематологический научный центр РАМН Способ определения парвовируса б19
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6642033B1 (en) 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
DK1238100T3 (da) * 1999-07-23 2006-01-23 Gen Probe Inc Polynucleotid-amplifikationsfremgangsmåde

Also Published As

Publication number Publication date
US20030170612A1 (en) 2003-09-11
BR0211191A (pt) 2006-05-23
US6936442B2 (en) 2005-08-30
WO2003002753A2 (en) 2003-01-09
WO2003002753A3 (en) 2005-04-14
BRPI0211191B1 (pt) 2015-09-15
EP1537235B1 (en) 2015-04-01
ES2537549T3 (es) 2015-06-09
JP2005511004A (ja) 2005-04-28
CN1636071A (zh) 2005-07-06
MXPA03011802A (es) 2004-04-02
SK15752003A3 (sk) 2005-01-03
JP2016182149A (ja) 2016-10-20
KR100888377B1 (ko) 2009-03-13
NZ530602A (en) 2006-02-24
AU2002318450B2 (en) 2007-11-22
HK1080516B (zh) 2008-01-25
RU2301263C2 (ru) 2007-06-20
CZ20033516A3 (cs) 2005-02-16
HK1080516A1 (en) 2006-04-28
BG108526A (bg) 2004-09-30
HUP0600779A2 (en) 2007-01-29
NO20035732L (no) 2004-02-27
US20050221300A1 (en) 2005-10-06
JP2012075440A (ja) 2012-04-19
JP6026401B2 (ja) 2016-11-16
AU2007231822B2 (en) 2011-01-27
BG66283B1 (bg) 2013-01-31
NO337901B1 (no) 2016-07-04
CN1324147C (zh) 2007-07-04
EP1537235A4 (en) 2007-10-03
HUP0600779A3 (en) 2010-03-29
BRPI0211191B8 (pt) 2021-07-27
NO20035732D0 (no) 2003-12-19
PL210849B1 (pl) 2012-03-30
EP1537235A2 (en) 2005-06-08
KR20050119220A (ko) 2005-12-21
CA2779653C (en) 2014-08-19
CA2779653A1 (en) 2003-01-09
RU2004102205A (ru) 2005-06-10
JP2009011324A (ja) 2009-01-22
KR20090003370A (ko) 2009-01-09
KR100944674B1 (ko) 2010-03-04
CA2451756A1 (en) 2003-01-09
HU230244B1 (hu) 2015-11-30
CZ308201B6 (cs) 2020-02-26
AU2007231822A1 (en) 2007-11-29
JP2014061007A (ja) 2014-04-10

Similar Documents

Publication Publication Date Title
MXPA03011802A (es) Ensayo de diagnostico para parvovirus b19.
FR2863861B1 (fr) Instrument chirurgical de type declipseuse pour implant rachidien.
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
TR200201187T2 (tr) Ters transkriptazın inhibitörleri olarak benzofenonlar
ECSP056181A (es) Compuestos Inhibidores de la Hepatitis C
EP1767546A4 (en) AN ANGIOGENESIS INHIBITING CHIMERIC PROTEIN AND ITS USE
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
WO2004096842A3 (en) Sars virus nucleotide and amino acid sequences and uses thereof
DE60026150D1 (de) Diagnostika und therapeutika für osteoporose
FR2823434B1 (fr) Instrument endoscopique bipolaire
CY1109995T1 (el) Συνθεσεις περιεχουσες προϊοντα σογιας
WO2005051318A3 (en) Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
ATE315380T1 (de) Epothilon zusammensetzungen
DE60214388D1 (de) Verbindungen, bei denen es sich um wirksame inhibitoren des na+/ca2+ austauschmechanismus handelt und die sich zur behandlung von arrhythmien eignen
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
WO2002062323A3 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
AP2009004857A0 (en) Oxidized proteins, their biological activity, and therapeutic and diagnostic measures,which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof
ATE395935T1 (de) An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47
WO2007030708A3 (en) Antimicrobial adzymes and uses thereof
ATE257822T1 (de) Aminoiminochinon und aminochinon alkaloid verbindungen als caspase inhibitoren
DK1339737T3 (da) Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus
EP1573055A4 (en) GENETIC DEPRESSION DIAGNOSIS
DE60028007D1 (de) Isolierung und charakterisierung eines abschaltungsgens aus n. crassa, und verwendungen davon

Legal Events

Date Code Title Description
RECP Rectifications of patent specification